A Comparative Study between Adductor Canal Block and IPACK Block vs ACB Alone vs IPACK Alone after Total Knee Arthroplasty for Post Operative Pain and Mobility - Trial PACTR202308887289470
Access comprehensive clinical trial information for PACTR202308887289470 through Pure Global AI's free database. This Phase 4 trial is sponsored by Ain shams university hospitals and is currently Recruitment Completed. The study focuses on Anaesthesia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
other
Sponsor & Location
Ain shams university hospitals
Self funded
Timeline & Enrollment
Phase 4
May 31, 2022
Dec 20, 2022
Summary
ACB + IPACK is a promising technique that offers improved pain management in the immediate postoperative period without affecting the motor function around the knee joint resulting in better ROM and ambulation compared to ACB alone and IPACK alone.Adductor canal block (ACB) is a peripheral nerve blockade technique that provides good pain control in patients undergoing total knee arthroplasty which however does not relieve posterior knee pain. The recent technique of an ultrasound-guided local anesthetic infiltration of the interspace between popliteal artery and the capsule of posterior knee (IPACK) has shown promising results in providing significant posterior knee analgesia without affecting the motor nerves In this study we will evaluate the effect of ACB plus IPACK vs ACB only VS IPACK only in patients post unilateral knee arthroplasty on post operative pain and mobility.Aim of This study is aiming to evaluate the effect of ACB plus IPACK vs ACB only VS IPACK only in patients post unilateral knee arthroplasty on post operative pain and mobility. To minimize the usage of total dose of narcotics postoperative
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202308887289470
Non-Device Trial